Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -118,181 | -89,135 | -58,762 | -26,067 | -75,777 |
| Depreciation Amortization | 2,412 | 1,800 | 1,108 | 367 | 325 |
| Accounts payable and accrued liabilities | -2,426 | -2,099 | -1,782 | 268 | 4,496 |
| Other Working Capital | 4,683 | 1,968 | 1,099 | 1,726 | 9,715 |
| Other Operating Activity | 19,483 | 13,812 | 10,013 | 3,481 | 9,794 |
| Operating Cash Flow | $-94,029 | $-73,654 | $-48,324 | $-20,225 | $-51,447 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,416 | -911 | -774 | -178 | -2,834 |
| Purchase Of Investment | -305,192 | -262,474 | -209,517 | -184,902 | -63,797 |
| Sale Of Investment | 215,867 | 138,804 | 41,069 | 15,000 | N/A |
| Other Investing Activity | -82 | -85 | 0 | 0 | -400 |
| Investing Cash Flow | $-90,823 | $-124,666 | $-169,222 | $-170,080 | $-67,031 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 92,700 | 91,216 | 91,177 | 91,160 | 113,121 |
| Financing Cash Flow | $92,700 | $91,216 | $91,177 | $91,160 | $113,121 |
| Exchange Rate Effect | -99 | -6 | -9 | -11 | -8 |
| Beginning Cash Position | 150,609 | 150,609 | 150,609 | 150,609 | 155,974 |
| End Cash Position | 58,358 | 43,499 | 24,231 | 51,453 | 150,609 |
| Net Cash Flow | $-92,251 | $-107,110 | $-126,378 | $-99,156 | $-5,365 |
| Free Cash Flow | |||||
| Operating Cash Flow | -94,029 | -73,654 | -48,324 | -20,225 | -51,447 |
| Capital Expenditure | -1,416 | -911 | -774 | -178 | -2,834 |
| Free Cash Flow | -95,445 | -74,565 | -49,098 | -20,403 | -54,281 |